surmount-1 tirzepatide trial weight loss non-diabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Relationship of early rapid weight

Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression

Our goal is to make high-level health accessible

and botanic extracts, to reduce the appearance of fine line and wrinkles for a firmer, more youthful, appearance.- - Improve skin texture and brightness with intense moisture and balance.Proven anti-aging properties fill-in and diminish the look of fine lines and wrinkles.

The authors reported statistically significant mean reductions in body weight from baseline across tirzepatide dose groups compared with placebo, extending the SURMOUNT-1 observations to participants with concurrent type 2 diabetes

Combining GHK-Cu with BPC-157 addresses both vascular and collagen aspects of repair

The angiogenesis promotion that makes BPC-157 potentially valuable for cardiovascular applications also raises theoretical questions